Dr Helena Kelly
Dr Helena Kelly is a Senior Lecturer in the School of Pharmacy and a Principal Investigator in the Tissue Engineering and Drug Delivery Research Groups at the Royal College of Surgeons in Ireland. She leads the Kelly Lab within the Drug Delivery Research Group at RCSI. An expert in pharmaceutics, Helena graduated with a BSc (Pharm) from Trinity College, Dublin (TCD) and subsequently carried out PhD research in the area of hydrogels and sustained drug delivery in the Department of Pharmaceutics, TCD.
A true translational scientist, Helena’s career has spanned both academic and industrial settings. After completing her PhD, Helena spent six years in the pharmaceutical and biopharmaceutical industry in Senior Project Manager Roles which gave her a wealth of experience in pharmaceutical production, scale up, technology transfer, clinical trial manufacture and the regulatory approval process. This experience has been vital to her current research roles as PI and Deputy Coordinator of both the AMCARE and DRIVE Research Consortia, which focus on developing hydrogel-based delivery systems for cell therapies for cardiac repair following myocardial infarction and to treat diabetes, respectively.
Helena returned to academia in 2008, when she was appointed Lecturer in Pharmaceutics in the School of Pharmacy, RCSI. From January 2012 to March 2014 she was seconded as Project Manager for the establishment of the Irish Institute of Pharmacy (IIoP). Since her return, Helena has been promoted to Senior Lecturer in the School of Pharmacy.
Helena was recently awarded an €191k Enterprise Ireland Commercialisation Fund as PI to develop “Chemogel”, a hydrogel-based delivery platform for targeted chemotherapy. The technology has potential application in a range of difficult to treat solid tumours including some of those with the poorest clinical outcomes.